XML 23 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income $ 93,192 $ 113,623
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Investment income (51,722) (11,741)
Depreciation and amortization 0 583
Equity-based compensation 0 1,497
Net realized and unrealized gain from consolidated funds’ investments (6,498) (39,134)
Accretion of original issue and market discount of consolidated funds’ investments, net (7,819) (7,223)
Distributions of investment income and settlements of derivative instruments (10,687) 10,898
Other non-cash items (35) 0
Cash flows due to changes in operating assets and liabilities:    
Net cash (used) provided in operating activities (156,554) (701,802)
Cash flows from investing activities:    
Purchases of U.S. Treasury and other securities 0 (4,425)
Corporate investments in funds and companies (43,547) (21,922)
Distributions and proceeds from corporate investments in funds and companies 71,563 14,031
Purchases of fixed assets 0 (96)
Net cash (used) provided by investing activities 28,016 (12,412)
Cash flows from financing activities:    
Net cash provided by financing activities 409,716 709,379
Effect of exchange rate changes on cash 5,300 3,686
Net (decrease) increase in cash and cash-equivalents 286,478 (1,149)
Cash and cash-equivalents, beginning balance 176,130 1,159,119
Cash and cash-equivalents, ending balance 462,608 1,157,970
Total cash and cash-equivalents 462,608 1,157,970
Oaktree Capital Group Excluding Consolidated Funds    
Cash flows due to changes in operating assets and liabilities:    
Decrease in deferred tax assets 0 505
Decrease (Increase) in other assets (975) 4,942
Decrease in net due from affiliates 164,302 312,556
Decrease in accrued compensation expense (9,483) (105,324)
Decrease in accounts payable, accrued expenses and other liabilities (1,252) (3,145)
Cash flows from financing activities:    
Capital contributions, net 149,214 111,211
Distributions to Class A unitholders (1,576) (94,964)
Distributions to OCGH unitholders (6,274) (54,703)
Distributions to preferred unitholders (6,829) (6,829)
Cash and cash-equivalents, ending balance 163,450 121,325
Total cash and cash-equivalents 163,450 121,325
Consolidated Funds    
Cash flows due to changes in operating assets and liabilities:    
Decrease in accounts payable, accrued expenses and other liabilities (977) (10,383)
Increase in dividends and interest receivable (4,696) (11,352)
Decrease (increase) in due from brokers 34,749 (39,158)
Increase in receivables for securities sold (28,500) (44,608)
Decrease (increase) in other assets (9,606) 12,401
Increase (decrease) in payables for securities purchased (21,333) 19,641
Purchases of securities (1,369,074) (3,092,034)
Proceeds from maturities and sales of securities 1,073,860 2,185,654
Cash flows from financing activities:    
Contributions from non-controlling interests 606,515 533,419
Distributions to non-controlling interests (29,533) (89,928)
Proceeds from debt obligations issued by CLOs 0 528,876
Payment of debt issuance costs 0 (2,275)
Repayment on debt obligations issued by CLOs 0 (237,540)
Borrowings on credit facilities 50,300 242,749
Repayments on credit facilities (352,101) (220,637)
Cash and cash-equivalents, ending balance 299,158 1,036,645
Total cash and cash-equivalents $ 299,158 $ 1,036,645